Vanda Sues FDA for ‘Capricious’ Denial of Fast-Track Status

In an unusual legal action, Vanda Pharmaceuticals is suing the FDA in a federal court for denying a request for Fast-Track designation for its investigational drug tradipitant after a series of failed attempts using other regulatory pathways.
Source: Drug Industry Daily